Human epidermal growth factor receptor 2 (HER2) gene amplification in non-muscle invasive urothelial bladder cancers: Identification of patients for targeted therapy.
Vinita AgrawalNiharika BhartiRakesh PandeyPublished in: Arab journal of urology (2020)
ASCO/CAP: American Society of Clinical Oncology/College of American Pathologists; DAB: 3,3'-diaminobenzidine; FISH: fluorescent in situ hybridisation; HER2: human epidermal growth factor receptor 2; IHC: immunohistochemistry;(N)MIBC: (non-) muscle-invasive bladder carcinoma; MPUC: micropapillary variant of urothelial bladder cancer; PFS: progression-free survival; TURBT: transurethral resection of bladder tumour.
Keyphrases
- epidermal growth factor receptor
- urinary tract
- tyrosine kinase
- advanced non small cell lung cancer
- endothelial cells
- free survival
- spinal cord injury
- end stage renal disease
- induced pluripotent stem cells
- skeletal muscle
- pluripotent stem cells
- ejection fraction
- chronic kidney disease
- prognostic factors
- palliative care
- quantum dots
- genome wide
- copy number
- young adults
- single molecule
- label free
- dna methylation
- living cells
- gene expression
- benign prostatic hyperplasia